Published in Elife on March 24, 2016
Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res (2016) 0.83
The Listeria monocytogenes PASTA Kinase PrkA and Its Substrate YvcK Are Required for Cell Wall Homeostasis, Metabolism, and Virulence. PLoS Pathog (2016) 0.81
The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases. Front Immunol (2017) 0.76
Immunometabolic Phenotype Alterations Associated with the Induction of Disease Tolerance and Persistent Asymptomatic Infection of Salmonella in the Chicken Intestine. Front Immunol (2017) 0.75
Does Elevated Glucose Promote Atherosclerosis? Pros and Cons. Circ Res (2016) 0.75
17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome. Sci Rep (2016) 0.75
Importance of Metabolic Adaptations in Francisella Pathogenesis. Front Cell Infect Microbiol (2017) 0.75
Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion. PLoS One (2016) 0.75
LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma. PLoS Pathog (2017) 0.75
Listeria monocytogenes cytosolic metabolism promotes replication, survival and evasion of innate immunity. Cell Microbiol (2017) 0.75
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature (2004) 14.80
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature (2009) 13.23
A role for mitochondria in NLRP3 inflammasome activation. Nature (2010) 13.21
Origin and physiological roles of inflammation. Nature (2008) 11.68
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature (2009) 10.83
Non-canonical inflammasome activation targets caspase-11. Nature (2011) 8.85
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol (2009) 7.93
Inflammasomes in health and disease. Nature (2012) 6.75
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol (2011) 6.53
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature (2011) 6.21
NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol (2010) 5.90
Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature (2013) 5.44
Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68
Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci U S A (2010) 4.57
Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med (2010) 4.52
The resurgence of covalent drugs. Nat Rev Drug Discov (2011) 4.09
Quantitative reactivity profiling predicts functional cysteines in proteomes. Nature (2010) 4.04
Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood (2010) 3.98
K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity (2013) 3.96
Mechanisms and functions of inflammasomes. Cell (2014) 3.75
Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol (2006) 3.44
Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature (2012) 3.40
Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol (2005) 2.90
A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol (2012) 2.59
An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride. Org Lett (2007) 1.97
Orchestration of metabolism by macrophages. Cell Metab (2012) 1.92
Tandem orthogonal proteolysis-activity-based protein profiling (TOP-ABPP)--a general method for mapping sites of probe modification in proteomes. Nat Protoc (2007) 1.87
Dynamics of intracellular bacterial replication at the single cell level. Proc Natl Acad Sci U S A (2010) 1.83
Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer (2013) 1.57
Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci (2014) 1.54
Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase). Proc Natl Acad Sci U S A (2003) 1.44
Salmonella require the fatty acid regulator PPARδ for the establishment of a metabolic environment essential for long-term persistence. Cell Host Microbe (2013) 1.41
On terminal alkynes that can react with active-site cysteine nucleophiles in proteases. J Am Chem Soc (2013) 1.32
A nonpeptidic cathepsin S activity-based probe for noninvasive optical imaging of tumor-associated macrophages. Chem Biol (2012) 1.27
Glucose and glycolysis are required for the successful infection of macrophages and mice by Salmonella enterica serovar typhimurium. Infect Immun (2009) 1.15
Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis. J Nucl Med (2013) 1.13
Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection. Nat Chem Biol (2012) 1.02
Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step. Elife (2014) 0.99
Specific inhibition of glyceraldehyde-3-phosphate dehydrogenase by koningic acid (heptelidic acid). J Antibiot (Tokyo) (1985) 0.98
Bacterial recognition pathways that lead to inflammasome activation. Immunol Rev (2015) 0.97
Reduced maximum capacity of glycolysis in brown adipose tissue of genetically obese, diabetic (db/db) mice and its restoration following treatment with a thermogenic beta-adrenoceptor agonist. FEBS Lett (1984) 0.97
Distribution and degradation of biotin-containing carboxylases in human cell lines. Biochem J (1985) 0.96
Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro. Cancer Res (1997) 0.93
Small-molecule inhibition of a depalmitoylase enhances Toxoplasma host-cell invasion. Nat Chem Biol (2013) 0.93
Pyroptotic death storms and cytopenia. Curr Opin Immunol (2013) 0.93
NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment. Arthritis Res Ther (2011) 0.92
Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2. Chem Res Toxicol (2004) 0.88
Oxidative metabolism enables Salmonella evasion of the NLRP3 inflammasome. J Exp Med (2014) 0.87
A unique small molecule inhibitor of enolase clarifies its role in fundamental biological processes. ACS Chem Biol (2013) 0.86
Decoding the dynamics of cellular metabolism and the action of 3-bromopyruvate and 2-deoxyglucose using pulsed stable isotope-resolved metabolomics. Cancer Metab (2014) 0.84
Nutritional and metabolic requirements for the infection of HeLa cells by Salmonella enterica serovar Typhimurium. PLoS One (2014) 0.81
Koningic acid (heptelidic acid) inhibition of glyceraldehyde-3-phosphate dehydrogenases from various sources. Biochim Biophys Acta (1992) 0.79
Chemical Strategies To Target Bacterial Virulence. Chem Rev (2017) 0.79
Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci Transl Med (2017) 0.76
Deletion of the rodent malaria ortholog for falcipain-1 highlights differences between hepatic and blood stage merozoites. PLoS Pathog (2017) 0.75